In February 2017, by 47% The Gold jewellery exports from India have fallen due to the jewellery routed through UAE is badly impacted.

The two major factors impacting the gold export from India is UAE w.e.f from January 1st, 2017 imposes 5% import duty on jewellery and The Indian government has a 10% import duty on gold imported for making jewellery.

In January Indian Gold jewellery exports fell by 24% and in February further by 47.52% and India’s market share has been gained by competitors like China. By Indians exporters and jewelry manufacturers, to avoid 5% import levy many manufacturing units are being set up in UAE. For, the same the gold artisans are moving to UAE and about 20% of Indian jewellery business might move to UAE.

The import duty on gold the Indian government should cut, expected by the government and stop the fall in Gold jewellery exports make it below 5%. As per a data made by Gems and Jewellery Export Promotion Council (GJEPC), which shows that in February 2017, gold jewellery exports fell to Rs 2,810.60 crore from Rs 5,355.47 crore in comparison to February 2016.

If this situation continues, to UAE, Indian exporters will be forced to either look at other markets and routes or think about moving facilities. The industry has been impacted badly due to the latest move of 1% excise duty and other supply restriction.

The post In Feb Indian Gold Jewellery Exports Down 47% appeared first on Trade Genius.

During the second half of this fiscal, there is a rise in exports forecasted by Pharmexcil. There has been seen a rise of 9.7% for the pharma exports of India and in the last fiscal reached to $16.89 billion. The present quarter of January to ¬March from that of October-¬December 2016, will take the export growth even higher for the pharma body.

At the US Food and Drug Administration (USFDA), from India, about 700 drug manufacturing units are registered. In 2016, At least 30% of the USFDA granted abbreviated new drug applications from India. Hence, in the next fiscal, it shows that the generic exports are going to rise.

In 2015, The Indian pharma companies were granted 388 ANDAs and in 2016386 ANDAs till the month of November. To the markets of US and Europe, about 50% of the drugs produced in India are being shipped which have very high standards of regulation.

The pharma exports are stable, in terms of volume. The pharma exports have fallen by 1.96% in terms of value and during April¬-October in FY 2016-17 reached to $ 9,848.2 million from the value in the same period of FY 2015-16.

From September 2015, the US has been controlling the prices of generics which can have an impact on the Indian Pharma industry. By more export volume this fall in value can be balanced.

The post In The Third Quarter Of FY2017 Indian Pharma Exports Show An Increase appeared first on Trade Genius.